EUVIMEDEUVIMED entdecken
Crossref

Long-Term Nephrotoxicity of 177 Lu-PSMA Radioligand Therapy

Lisa Steinhelfer, Lukas Lunger, Lisena Cala, Christian H Pfob, Constantin Lapa, Philipp E Hartrampf, Andreas K Buck, Hannah Schäfer, Christoph Schmaderer, Robert Tauber, Julia Brosch-Lenz, Bernhard Haller und 4 weitere

Journal of Nuclear Medicine · 2024-01 · 65 (1) · 79-84

DOI: 10.2967/jnumed.123.265986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 19.10.2023. Verfasst von Lisa Steinhelfer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-emitting 177Lu targeting prostate-specific membrane antigen (PSMA) is an approved treatment option for metastatic castration-resistant prostate cancer. Data on its long-term nephrotoxicity are sparse. This study aimed to retrospectively evaluate post-177Lu-PSMA estimated glomerular filtration rate (eGFR) dynamics for at least 12 mo in a cohort of metastatic castration-resistant prostate cancer patients. Methods: The institutional databases of 3 German tertiary referral centers identified 106 patients who underwent at least 4 cycles of 177Lu-PSMA and had at least 12 mo of eGFR follow-up data. eGFR (by the Chronic Kidney Disease Epidemiology Collaboration formula) at 3, 6, and 12 mo after 177Lu-PSMA radioligand therapy was estimated using monoexponentially fitted curves through available eGFR data. eGFR changes were grouped (≥15%-

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantMaleHumansRetrospective StudiesTreatment OutcomeProstate-Specific AntigenDipeptidesLutetiumHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

PSMAlutetiummCRPCnephrotoxicityradioligand therapy

Substanzen

Prostate-Specific AntigenDipeptidesLutetiumHeterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • Department of Nuclear Medicine, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Radiology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Urology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; lukas.lunger@tum.de.
  • Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany.
  • Department of Nephrology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; and.

Zitieren

APA

Steinhelfer, L., Lunger, L., Cala, L., Pfob, C. H., Lapa, C., Hartrampf, P. E., Buck, A. K., Schäfer, H., Schmaderer, C., Tauber, R., Brosch-Lenz, J., Haller, B., Meissner, V. H., Knorr, K., Weber, W. A., & Eiber, M. (2024). Long-Term Nephrotoxicity of 177 Lu-PSMA Radioligand Therapy. Journal of Nuclear Medicine, 65(1), 79-84. https://doi.org/10.2967/jnumed.123.265986

Vancouver

Steinhelfer L, Lunger L, Cala L, Pfob CH, Lapa C, Hartrampf PE, et al. Long-Term Nephrotoxicity of 177 Lu-PSMA Radioligand Therapy. Journal of Nuclear Medicine. 2024;65(1):79-84. doi:10.2967/jnumed.123.265986

BibTeX
@article{Steinhelfer2024,
  author = {Steinhelfer, Lisa and Lunger, Lukas and Cala, Lisena and Pfob, Christian H and Lapa, Constantin and Hartrampf, Philipp E and Buck, Andreas K and Schäfer, Hannah and Schmaderer, Christoph and Tauber, Robert and Brosch-Lenz, Julia and Haller, Bernhard and Meissner, Valentin H and Knorr, Karina and Weber, Wolfgang A and Eiber, Matthias},
  title = {Long-Term Nephrotoxicity of 177 Lu-PSMA Radioligand Therapy},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {1},
  pages = {79--84},
  doi = {10.2967/jnumed.123.265986}
}
Kostenlos starten →